Altimmune Inc. (ALT)
NASDAQ: ALT
· Real-Time Price · USD
3.90
-0.03 (-0.76%)
At close: Oct 03, 2025, 2:29 PM
-0.76% (1D)
| Bid | 3.9 |
| Market Cap | 344.64M |
| Revenue (ttm) | 20K |
| Net Income (ttm) | -87.75M |
| EPS (ttm) | -1.21 |
| PE Ratio (ttm) | -3.23 |
| Forward PE | -2.82 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.91 |
| Volume | 1,767,371 |
| Avg. Volume (20D) | 3,049,692 |
| Open | 3.94 |
| Previous Close | 3.93 |
| Day's Range | 3.88 - 4.06 |
| 52-Week Range | 2.90 - 11.16 |
| Beta | 0.06 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for ALT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAltimmune Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-53.18%
Altimmune shares are trading lower after the compa...
Unlock content with
Pro Subscription
6 months ago
+13.85%
Altimmune shares are trading higher amid rumours several large pharmaceutical organizations are interested in the company.
